-+ 0.00%
-+ 0.00%
-+ 0.00%

Maxim Group Downgrades Aytu BioPharma to Hold

Benzinga·11/17/2026 17:38:04
Listen to the news
Maxim Group analyst Naz Rahman downgrades Aytu BioPharma (NASDAQ:AYTU) from Buy to Hold.